Platelets in sepsis: An update on experimental models and clinical data

Frontiers in Immunology

Volumn 10, Issue JULY, 2019, Pages

  Assinger, Alice ^a   Schrottmaier, Waltraud C ^a   Salzmann, Manuel ^a   Rayes, Julie ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Infection; Inflammation; Platelets; Sepsis; Thrombocytopenia

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA2 INTEGRIN; BETA3 INTEGRIN; CD23 ANTIGEN; CELL ADHESION MOLECULE; FC RECEPTOR; GLYCOPROTEIN IB; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; GLYCOPROTEIN VI; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; LECTIN RECEPTOR; MURAMYL DIPEPTIDE; NITRIC OXIDE SYNTHASE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PADGEM PROTEIN; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 1; PURINERGIC P2Y RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; THROMBOCYTE ANTIBODY; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

ACUTE KIDNEY FAILURE; ANTIBODY SPECIFICITY; ARTICLE; BRAIN DYSFUNCTION; CASPASE ACTIVATION AND RECRUITMENT DOMAIN; CIRCULATION; CYTOTOXICITY; DISSEMINATED INTRAVASCULAR CLOTTING; ERYTHROPHAGOCYTOSIS; GASTROINTESTINAL TRACT; GENETICS; HUMAN; IMMUNOMODULATION; IMMUNORECEPTOR TYROSINE BASED INHIBITION MOTIF; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LIVER FUNCTION; LUNG FUNCTION; MIXED INFECTION; MULTIPLE ORGAN FAILURE; NONHUMAN; PLATELET COUNT; PROTEIN PHOSPHORYLATION; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; TISSUE INJURY; TISSUE REPAIR; ANIMAL; BLOOD CLOTTING; HEMOSTASIS; INFLAMMATION; PATHOLOGY; PHYSIOLOGY; THEORETICAL MODEL;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; HEMOSTASIS; HUMANS; INFLAMMATION; MODELS, THEORETICAL; SEPSIS;

EID: 85069440086     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2019.01687     Document Type: Article

References (198)

1. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. (2016) 315:801-10. doi: 10.1001/jama.2016.0287 CrossRef Full Text | Google Scholar
2. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: From cellular dysfunctions to immunotherapy. Nat Rev Immunol. (2013) 13:862-74. doi: 10.1038/nri3552 PubMed Abstract | CrossRef Full Text | Google Scholar
3. Martin GS. Sepsis, severe sepsis and septic shock: Changes in incidence, pathogens and outcomes. Expert Rev Anti Infect Ther. (2012) 10:701-6. doi: 10.1586/eri.12.50 PubMed Abstract | CrossRef Full Text | Google Scholar
4. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. (2013) 369:2063. doi: 10.1056/NEJMra1208623 CrossRef Full Text | Google Scholar
5. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity. (2011) 34:637-50. doi: 10.1016/j.immuni.2011.05.006 PubMed Abstract | CrossRef Full Text | Google Scholar
6. Hoesel B, Schmid JA. The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer. (2013) 12:86. doi: 10.1186/1476-4598-12-86 PubMed Abstract | CrossRef Full Text | Google Scholar
7. Greenlee-Wacker MC. Clearance of apoptotic neutrophils and resolution of inflammation. Immunol Rev. (2016) 273:357-70. doi: 10.1111/imr.12453 PubMed Abstract | CrossRef Full Text | Google Scholar
8. Mayr FB, Yende S, Angus DC. Epidemiology of severe sepsis. Virulence. (2014) 5:4-11. doi: 10.4161/viru.27372 PubMed Abstract | CrossRef Full Text | Google Scholar
9. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. (2003) 348:1546-54. doi: 10.1056/NEJMoa022139 PubMed Abstract | CrossRef Full Text | Google Scholar
10. Gupta S, Sakhuja A, Kumar G, McGrath E, Nanchal RS, Kashani KB. Culture-negative severe sepsis: nationwide trends and outcomes. Chest. (2016) 150:1251-9. doi: 10.1016/j.chest.2016.08.1460 PubMed Abstract | CrossRef Full Text | Google Scholar
11. Opal SM, van der Poll T. Endothelial barrier dysfunction in septic shock. J Intern Med. (2015) 277:277-93. doi: 10.1111/joim.12331 PubMed Abstract | CrossRef Full Text | Google Scholar
12. Baskurt OK, Gelmont D, Meiselman HJ. Red blood cell deformability in sepsis. Am J Respir Crit Care Med. (1998) 157:421-7. doi: 10.1164/ajrccm.157.2.9611103 PubMed Abstract | CrossRef Full Text | Google Scholar
13. Pena OM, Hancock DG, Lyle NH, Linder A, Russell JA, Xia J, et al. An endotoxin tolerance signature predicts sepsis and organ dysfunction at initial clinical presentation. EBioMedicine. (2014) 1:64-71. doi: 10.1016/j.ebiom.2014.10.003 PubMed Abstract | CrossRef Full Text | Google Scholar
14. Girardot T, Rimmele T, Venet F, Monneret G. Apoptosis-induced lymphopenia in sepsis and other severe injuries. Apoptosis. (2017) 22:295-305. doi: 10.1007/s10495-016-1325-3 PubMed Abstract | CrossRef Full Text | Google Scholar
15. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. (2011) 306:2594-605. doi: 10.1001/jama.2011.1829 PubMed Abstract | CrossRef Full Text | Google Scholar
16. Ho J, Yu J, Wong SH, Zhang L, Liu X, Wong WT, et al. Autophagy in sepsis: Degradation into exhaustion? Autophagy. (2016) 12:1073-82. doi: 10.1080/15548627.2016.1179410 PubMed Abstract | CrossRef Full Text | Google Scholar
17. Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol. (2008) 8:776-87. doi: 10.1038/nri2402 PubMed Abstract | CrossRef Full Text | Google Scholar
18. Beristain-Covarrubias N, Perez-Toledo M, Flores-Langarica A, Zuidscherwoude M, Hitchcock JR, Channell WM, et al. Salmonella-induced thrombi in mice develop asynchronously in the spleen and liver and are not effective bacterial traps. Blood. (2018) 133:600-4. doi: 10.1182/blood-2018-08-867267 CrossRef Full Text | Google Scholar
19. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. (2013) 13:34-45. doi: 10.1038/nri3345 PubMed Abstract | CrossRef Full Text | Google Scholar
20. Levi M, Lowenberg EC. Thrombocytopenia in critically ill patients. Semin Thromb Hemost. (2008) 34:417-24. doi: 10.1055/s-0028-1092871 PubMed Abstract | CrossRef Full Text | Google Scholar
21. Shibazaki M, Nakamura M, Endo Y. Biphasic, organ-specific, and strain-specific accumulation of platelets induced in mice by a lipopolysaccharide from Escherichia coli and its possible involvement in shock. Infect Immun. (1996) 64:5290-4. PubMed Abstract | Google Scholar
22. Sigurdsson GH, Christenson JT, el-Rakshy MB, Sadek S. Intestinal platelet trapping after traumatic and septic shock. An early sign of sepsis and multiorgan failure in critically ill patients? Crit Care Med. (1992) 20:458-67. doi: 10.1097/00003246-199204000-00005 PubMed Abstract | CrossRef Full Text | Google Scholar
23. Andonegui G, Kerfoot SM, McNagny K, Ebbert KV, Patel KD, Kubes P. Platelets express functional Toll-like receptor-4. Blood. (2005) 106:2417-23. doi: 10.1182/blood-2005-03-0916 PubMed Abstract | CrossRef Full Text | Google Scholar
24. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med. (1999) 341:586-92. doi: 10.1056/NEJM199908193410807 PubMed Abstract | CrossRef Full Text | Google Scholar
25. Claushuis TA, van Vught LA, Scicluna BP, Wiewel MA, Klein Klouwenberg PM, Hoogendijk AJ, et al. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood. (2016) 127:3062-72. doi: 10.1182/blood-2015-11-680744 PubMed Abstract | CrossRef Full Text | Google Scholar
26. Tsirigotis P, Chondropoulos S, Frantzeskaki F, Stamouli M, Gkirkas K, Bartzeliotou A, et al. Thrombocytopenia in critically ill patients with severe sepsis/septic shock: Prognostic value and association with a distinct serum cytokine profile. J Crit Care. (2016) 32:9-15. doi: 10.1016/j.jcrc.2015.11.010 PubMed Abstract | CrossRef Full Text | Google Scholar
27. Mavrommatis AC, Theodoridis T, Orfanidou A, Roussos C, Christopoulou-Kokkinou V, Zakynthinos S. Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med. (2000) 28:451-7. doi: 10.1097/00003246-200002000-00027 PubMed Abstract | CrossRef Full Text | Google Scholar
28. Baughman RP, Lower EE, Flessa HC, Tollerud DJ. Thrombocytopenia in the intensive care unit. Chest. (1993) 104:1243-7. doi: 10.1378/chest.104.4.1243 PubMed Abstract | CrossRef Full Text | Google Scholar
29. Vincent JL, Zhang H, Szabo C, Preiser JC. Effects of nitric oxide in septic shock. Am J Respir Crit Care Med. (2000) 161:1781-5. doi: 10.1164/ajrccm.161.6.9812004 PubMed Abstract | CrossRef Full Text | Google Scholar
30. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. (2003) 101:3765-77. doi: 10.1182/blood-2002-06-1887 PubMed Abstract | CrossRef Full Text | Google Scholar
31. Haak BW, Wiersinga WJ. The role of the gut microbiota in sepsis. Lancet Gastroenterol Hepatol. (2017) 2:135-43. doi: 10.1016/S2468-1253(16)30119-4 PubMed Abstract | CrossRef Full Text | Google Scholar
32. Zarbock A, Ley K. The role of platelets in acute lung injury (ALI). Front Biosci. (2009) 14:150-8. doi: 10.2741/3236 PubMed Abstract | CrossRef Full Text | Google Scholar
33. Yan J, Li S, Li S. The role of the liver in sepsis. Int Rev Immunol. (2014) 33:498-510. doi: 10.3109/08830185.2014.889129 PubMed Abstract | CrossRef Full Text | Google Scholar
34. Gomez H, Kellum JA. Sepsis-induced acute kidney injury. Curr Opin Crit Care. (2016) 22:546-53. doi: 10.1097/MCC.0000000000000356 PubMed Abstract | CrossRef Full Text | Google Scholar
35. Sonneville R, Verdonk F, Rauturier C, Klein IF, Wolff M, Annane D, et al. Understanding brain dysfunction in sepsis. Ann Intensive Care. (2013) 3:15. doi: 10.1186/2110-5820-3-15 PubMed Abstract | CrossRef Full Text | Google Scholar
36. Kral JB, Schrottmaier WC, Salzmann M, Assinger A. Platelet Interaction with Innate Immune Cells. Transfus Med Hemother. (2016) 43:78-88. doi: 10.1159/000444807 PubMed Abstract | CrossRef Full Text | Google Scholar
37. Schrottmaier WC, Kral JB, Badrnya S, Assinger A. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes. Thromb Haemost. (2015) 114:478-89. doi: 10.1160/TH14-11-0943 PubMed Abstract | CrossRef Full Text | Google Scholar
38. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood. (2006) 107:637-41. doi: 10.1182/blood-2005-06-2202 PubMed Abstract | CrossRef Full Text | Google Scholar
39. Handtke S, Steil L, Greinacher A, Thiele T. Toward the relevance of platelet subpopulations for transfusion medicine. Front Med. (2018) 5:17. doi: 10.3389/fmed.2018.00017 PubMed Abstract | CrossRef Full Text | Google Scholar
40. Koupenova M, Mick E, Mikhalev E, Benjamin EJ, Tanriverdi K, Freedman JE. Sex differences in platelet toll-like receptors and their association with cardiovascular risk factors. Arterioscler Thromb Vasc Biol. (2015) 35:1030-7. doi: 10.1161/ATVBAHA.114.304954 PubMed Abstract | CrossRef Full Text | Google Scholar
41. Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. (2012) 120:e73-82. doi: 10.1182/blood-2012-04-416594 PubMed Abstract | CrossRef Full Text | Google Scholar
42. Cognasse F, Nguyen KA, Damien P, McNicol A, Pozzetto B, Hamzeh-Cognasse H, et al. The inflammatory role of platelets via their TLRs and siglec receptors. Front Immunol. (2015) 6:83. doi: 10.3389/fimmu.2015.00083 PubMed Abstract | CrossRef Full Text | Google Scholar
43. Zeiler M, Moser M, Mann M. Copy number analysis of the murine platelet proteome spanning the complete abundance range. Mol Cell Proteomics. (2014) 13:3435-45. doi: 10.1074/mcp.M114.038513 PubMed Abstract | CrossRef Full Text | Google Scholar
44. O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev. (2008) 226:10-8. doi: 10.1111/j.1600-065X.2008.00701.x PubMed Abstract | CrossRef Full Text | Google Scholar
45. Beaulieu LM, Lin E, Morin KM, Tanriverdi K, Freedman JE. Regulatory effects of TLR2 on megakaryocytic cell function. Blood. (2011) 117:5963-74. doi: 10.1182/blood-2010-09-304949 PubMed Abstract | CrossRef Full Text | Google Scholar
46. Blair P, Rex S, Vitseva O, Beaulieu L, Tanriverdi K, Chakrabarti S, et al. Stimulation of Toll-like receptor 2 in human platelets induces a thromboinflammatory response through activation of phosphoinositide 3-kinase. Circ Res. (2009) 104:346-54. doi: 10.1161/CIRCRESAHA.108.185785 PubMed Abstract | CrossRef Full Text | Google Scholar
47. Assinger A, Buchberger E, Laky M, Esfandeyari A, Brostjan C, Volf I. Periodontopathogens induce soluble P-selectin release by endothelial cells and platelets. Thromb Res. (2011) 127:e20-6. doi: 10.1016/j.thromres.2010.10.023 PubMed Abstract | CrossRef Full Text | Google Scholar
48. Koupenova M, Vitseva O, MacKay CR, Beaulieu LM, Benjamin EJ, Mick E, et al. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood. (2014) 124:791-802. doi: 10.1182/blood-2013-11-536003 PubMed Abstract | CrossRef Full Text | Google Scholar
49. Thon JN, Peters CG, Machlus KR, Aslam R, Rowley J, Macleod H, et al. T granules in human platelets function in TLR9 organization and signaling. J Cell Biol. (2012) 198:561-74. doi: 10.1083/jcb.201111136 PubMed Abstract | CrossRef Full Text | Google Scholar
50. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med. (2007) 13:463-9. doi: 10.1038/nm1565 PubMed Abstract | CrossRef Full Text | Google Scholar
51. Semple JW, Aslam R, Kim M, Speck ER, Freedman J. Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets. Blood. (2007) 109:4803-5. doi: 10.1182/blood-2006-12-062695 PubMed Abstract | CrossRef Full Text | Google Scholar
52. Bentala H, Verweij WR, Huizinga-Van der Vlag A, van Loenen-Weemaes AM, Meijer DK, Poelstra K. Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide. Shock. (2002) 18:561-6. doi: 10.1097/00024382-200212000-00013 PubMed Abstract | CrossRef Full Text | Google Scholar
53. Schromm AB, Brandenburg K, Loppnow H, Zahringer U, Rietschel ET, Carroll SF, et al. The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J Immunol. (1998) 161:5464-71. PubMed Abstract | Google Scholar
54. Yang WH, Heithoff DM, Aziz PV, Haslund-Gourley B, Westman JS, Narisawa S, et al. Accelerated aging and clearance of host anti-inflammatory enzymes by discrete pathogens fuels sepsis. Cell Host Microbe. (2018) 24:500-513 e5. doi: 10.1016/j.chom.2018.09.011 PubMed Abstract | CrossRef Full Text | Google Scholar
55. Grewal PK, Aziz PV, Uchiyama S, Rubio GR, Lardone RD, Le D, et al. Inducing host protection in pneumococcal sepsis by preactivation of the Ashwell-Morell receptor. Proc Natl Acad Sci USA. (2013) 110:20218-23. doi: 10.1073/pnas.1313905110 PubMed Abstract | CrossRef Full Text | Google Scholar
56. Claushuis TAM, Van Der Veen AIP, Horn J, Schultz MJ, Houtkooper RH, Van 't Veer C, et al. Platelet Toll-like receptor expression and activation induced by lipopolysaccharide and sepsis. Platelets. (2018) 30:296-304. doi: 10.1080/09537104.2018.1445841 PubMed Abstract | CrossRef Full Text | Google Scholar
57. Boukour S, Masse JM, Benit L, Dubart-Kupperschmitt A, Cramer EM. Lentivirus degradation and DC-SIGN expression by human platelets and megakaryocytes. J Thromb Haemost. (2006) 4:426-35. doi: 10.1111/j.1538-7836.2006.01749.x PubMed Abstract | CrossRef Full Text | Google Scholar
58. Tsicopoulos A, Joseph M. The role of CD23 in allergic disease. Clin Exp Allergy. (2000) 30:602-5. doi: 10.1046/j.1365-2222.2000.00871.x PubMed Abstract | CrossRef Full Text | Google Scholar
59. Joseph M, Gounni AS, Kusnierz JP, Vorng H, Sarfati M, Kinet JP, et al. Expression and functions of the high-affinity IgE receptor on human platelets and megakaryocyte precursors. Eur J Immunol. (1997) 27:2212-8. doi: 10.1002/eji.1830270914 PubMed Abstract | CrossRef Full Text | Google Scholar
60. Klouche M, Klinger MH, Kuhnel W, Wilhelm D. Endocytosis, storage, and release of IgE by human platelets: Differences in patients with type I allergy and nonatopic subjects. J Allergy Clin Immunol. (1997) 100:235-41. doi: 10.1016/S0091-6749(97)70230-6 PubMed Abstract | CrossRef Full Text | Google Scholar
61. Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE. NOD proteins: Regulators of inflammation in health and disease. Nat Rev Immunol. (2014) 14:9-23. doi: 10.1038/nri3565 PubMed Abstract | CrossRef Full Text | Google Scholar
62. Zhang S, Zhang S, Hu L, Zhai L, Xue R, Ye J, et al. Nucleotide-binding oligomerization domain 2 receptor is expressed in platelets and enhances platelet activation and thrombosis. Circulation. (2015) 131:1160-70. doi: 10.1161/CIRCULATIONAHA.114.013743 PubMed Abstract | CrossRef Full Text | Google Scholar
63. Plummer C, Wu H, Kerrigan SW, Meade G, Cox D, Ian Douglas CW. A serine-rich glycoprotein of Streptococcus sanguis mediates adhesion to platelets via GPIb. Br J Haematol. (2005) 129:101-9. doi: 10.1111/j.1365-2141.2005.05421.x PubMed Abstract | CrossRef Full Text | Google Scholar
64. Hartleib J, Kohler N, Dickinson RB, Chhatwal GS, Sixma JJ, Hartford OM, et al. Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood. (2000) 96:2149-56. PubMed Abstract | Google Scholar
65. Bennett JS. Structure and function of the platelet integrin alphaIIbbeta3. J Clin Invest. (2005) 115:3363-9. doi: 10.1172/JCI26989 PubMed Abstract | CrossRef Full Text | Google Scholar
66. Brennan MP, Loughman A, Devocelle M, Arasu S, Chubb AJ, Foster TJ, et al. Elucidating the role of Staphylococcus epidermidis serine-aspartate repeat protein G in platelet activation. J Thromb Haemost. (2009) 7:1364-72. doi: 10.1111/j.1538-7836.2009.03495.x PubMed Abstract | CrossRef Full Text | Google Scholar
67. Coburn J, Leong JM, Erban JK. Integrin alpha IIb beta 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc Natl Acad Sci USA. (1993) 90:7059-63. doi: 10.1073/pnas.90.15.7059 PubMed Abstract | CrossRef Full Text | Google Scholar
68. Siboo IR, Cheung AL, Bayer AS, Sullam PM. Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect Immun. (2001) 69:3120-7. doi: 10.1128/IAI.69.5.3120-3127.2001 PubMed Abstract | CrossRef Full Text | Google Scholar
69. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, et al. A dual thrombin receptor system for platelet activation. Nature. (1998) 394:690-4. doi: 10.1038/29325 PubMed Abstract | CrossRef Full Text | Google Scholar
70. Qian K, Xie F, Gibson AW, Edberg JC, Kimberly RP, Wu J. Functional expression of IgA receptor FcalphaRI on human platelets. J Leukoc Biol. (2008) 84:1492-500. doi: 10.1189/jlb.0508327 PubMed Abstract | CrossRef Full Text | Google Scholar
71. Hasegawa S, Pawankar R, Suzuki K, Nakahata T, Furukawa S, Okumura K, et al. Functional expression of the high affinity receptor for IgE (FcepsilonRI) in human platelets and its' intracellular expression in human megakaryocytes. Blood. (1999) 93:2543-51. PubMed Abstract | Google Scholar
72. Tomiyama Y, Kunicki TJ, Zipf TF, Ford SB, Aster RH. Response of human platelets to activating monoclonal antibodies: Importance of Fc gamma RII (CD32) phenotype and level of expression. Blood. (1992) 80:2261-8. PubMed Abstract | Google Scholar
73. Arman M, Krauel K. Human platelet IgG Fc receptor FcgammaRIIA in immunity and thrombosis. J Thromb Haemost. (2015) 13:893-908. doi: 10.1111/jth.12905 PubMed Abstract | CrossRef Full Text | Google Scholar
74. Riaz AH, Tasma BE, Woodman ME, Wooten RM, Worth RG. Human platelets efficiently kill IgG-opsonized E. coli. FEMS Immunol Med Microbiol. (2012) 65:78-83. doi: 10.1111/j.1574-695X.2012.00945.x PubMed Abstract | CrossRef Full Text | Google Scholar
75. Leon C, Ravanat C, Freund M, Cazenave JP, Gachet C. Differential involvement of the P2Y1 and P2Y12 receptors in platelet procoagulant activity. Arterioscler Thromb Vasc Biol. (2003) 23:1941-7. doi: 10.1161/01.ATV.0000092127.16125.E6 PubMed Abstract | CrossRef Full Text | Google Scholar
76. Salat A, Bodingbauer G, Boehm D, Murabito M, Tochkow E, Sautner T, et al. Changes of platelet surface antigens in patients suffering from abdominal septic shock. Thromb Res. (1999) 95:289-94. doi: 10.1016/S0049-3848(99)00046-8 PubMed Abstract | CrossRef Full Text | Google Scholar
77. Gawaz M, Dickfeld T, Bogner C, Fateh-Moghadam S, Neumann FJ. Platelet function in septic multiple organ dysfunction syndrome. Intensive Care Med. (1997) 23:379-85. doi: 10.1007/s001340050344 PubMed Abstract | CrossRef Full Text | Google Scholar
78. Layios N, Delierneux C, Hego A, Huart J, Gosset C, Lecut C, et al. Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: A prospective pilot study. Intensive Care Med Exp. (2017) 5:32. doi: 10.1186/s40635-017-0145-2 PubMed Abstract | CrossRef Full Text | Google Scholar
79. Montague SJ, Delierneux C, Lecut C, Layios N, Dinsdale RJ, Lee CS, et al. Soluble GPVI is elevated in injured patients: Shedding is mediated by fibrin activation of GPVI. Blood Adv. (2018) 2:240-51. doi: 10.1182/bloodadvances.2017011171 PubMed Abstract | CrossRef Full Text | Google Scholar
80. Laursen MA, Larsen JB, Hvas AM. Platelet function in disseminated intravascular coagulation: A systematic review. Platelets. (2018) 29:238-48. doi: 10.1080/09537104.2018.1442567 PubMed Abstract | CrossRef Full Text | Google Scholar
81. Woth G, Varga A, Ghosh S, Krupp M, Kiss T, Bogar L, et al. Platelet aggregation in severe sepsis. J Thromb Thrombolysis. (2011) 31:6-12. doi: 10.1007/s11239-010-0486-0 PubMed Abstract | CrossRef Full Text | Google Scholar
82. Yaguchi A, Lobo FL, Vincent JL, Pradier O. Platelet function in sepsis. J Thromb Haemost. (2004) 2:2096-102. doi: 10.1111/j.1538-7836.2004.01009.x PubMed Abstract | CrossRef Full Text | Google Scholar
83. Vincent JL, Yagushi A, Pradier O. Platelet function in sepsis. Crit Care Med. (2002) 30:S313-7. doi: 10.1097/00003246-200205001-00022 PubMed Abstract | CrossRef Full Text | Google Scholar
84. Gawaz M, Fateh-Moghadam S, Pilz G, Gurland HJ, Werdan K. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest. (1995) 25:843-51. doi: 10.1111/j.1365-2362.1995.tb01694.x CrossRef Full Text | Google Scholar
85. Rondina MT, Carlisle M, Fraughton T, Brown SM, Miller RR III, Harris ES, et al. Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock. J Gerontol A Biol Sci Med Sci. (2015) 70:225-31. doi: 10.1093/gerona/glu082 PubMed Abstract | CrossRef Full Text | Google Scholar
86. Arman M, Krauel K, Tilley DO, Weber C, Cox D, Greinacher A, et al. Amplification of bacteria-induced platelet activation is triggered by FcgammaRIIA, integrin alphaIIbbeta3, and platelet factor 4. Blood. (2014) 123:3166-74. doi: 10.1182/blood-2013-11-540526 PubMed Abstract | CrossRef Full Text | Google Scholar
87. Hamzeh-Cognasse H, Damien P, Chabert A, Pozzetto B, Cognasse F, Garraud O. Platelets and infections - complex interactions with bacteria. Front Immunol. (2015) 6:82. doi: 10.3389/fimmu.2015.00082 PubMed Abstract | CrossRef Full Text | Google Scholar
88. Cox D, Kerrigan SW, Watson SP. Platelets and the innate immune system: Mechanisms of bacterial-induced platelet activation. J Thromb Haemost. (2011) 9:1097-107. doi: 10.1111/j.1538-7836.2011.04264.x PubMed Abstract | CrossRef Full Text | Google Scholar
89. Ghuman H, Shepherd-Roberts A, Watson S, Zuidscherwoude M, Watson SP, Voelz K. Mucor circinelloides induces platelet aggregation through integrin alphaIIbbeta3 and FcgammaRIIA. Platelets. (2018) 30:256-63. doi: 10.1080/09537104.2017.1420152 PubMed Abstract | CrossRef Full Text | Google Scholar
90. Svensson L, Baumgarten M, Morgelin M, Shannon O. Platelet activation by Streptococcus pyogenes leads to entrapment in platelet aggregates, from which bacteria subsequently escape. Infect Immun. (2014) 82:4307-14. doi: 10.1128/IAI.02020-14 PubMed Abstract | CrossRef Full Text | Google Scholar
91. Markiewski MM, DeAngelis RA, Lambris JD. Complexity of complement activation in sepsis. J Cell Mol Med. (2008) 12:2245-54. doi: 10.1111/j.1582-4934.2008.00504.x PubMed Abstract | CrossRef Full Text | Google Scholar
92. Vanderschueren S, De Weerdt A, Malbrain M, Vankersschaever D, Frans E, Wilmer A, et al. Thrombocytopenia and prognosis in intensive care. Crit Care Med. (2000) 28:1871-6. doi: 10.1097/00003246-200006000-00031 PubMed Abstract | CrossRef Full Text | Google Scholar
93. Sharma B, Sharma M, Majumder M, Steier W, Sangal A, Kalawar M. Thrombocytopenia in septic shock patients-a prospective observational study of incidence, risk factors and correlation with clinical outcome. Anaesth Intensive Care. (2007) 35:874-80. doi: 10.1177/0310057X0703500604 PubMed Abstract | CrossRef Full Text | Google Scholar
94. Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM. The frequency and clinical significance of thrombocytopenia complicating critical illness: A systematic review. Chest. (2011) 139:271-8. doi: 10.1378/chest.10-2243 PubMed Abstract | CrossRef Full Text | Google Scholar
95. Thiolliere F, Serre-Sapin AF, Reignier J, Benedit M, Constantin JM, Lebert C, et al. Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: Results of a prospective multicenter study. Intensive Care Med. (2013) 39:1460-8. doi: 10.1007/s00134-013-2963-3 PubMed Abstract | CrossRef Full Text | Google Scholar
96. Venkata C, Kashyap R, Farmer JC, Afessa B. Thrombocytopenia in adult patients with sepsis: Incidence, risk factors, and its association with clinical outcome. J Intensive Care. (2013) 1:9. doi: 10.1186/2052-0492-1-9 PubMed Abstract | CrossRef Full Text | Google Scholar
97. Akca S, Haji-Michael P, de Mendonca A, Suter P, Levi M, Vincent JL. Time course of platelet counts in critically ill patients. Crit Care Med. (2002) 30:753-6. doi: 10.1097/00003246-200204000-00005 PubMed Abstract | CrossRef Full Text | Google Scholar
98. Drews RE, Weinberger SE. Thrombocytopenic disorders in critically ill patients. Am J Respir Crit Care Med. (2000) 162:347-51. doi: 10.1164/ajrccm.162.2.ncc3-00 PubMed Abstract | CrossRef Full Text | Google Scholar
99. Dewitte A, Lepreux S, Villeneuve J, Rigothier C, Combe C, Ouattara A, et al. Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critical ill patients? Ann Intensive Care. (2017) 7:115. doi: 10.1186/s13613-017-0337-7 CrossRef Full Text | Google Scholar
100. Vincent JL, Castro P, Hunt BJ, Jorres A, Praga M, Rojas-Suarez J, et al. Thrombocytopenia in the ICU: Disseminated intravascular coagulation and thrombotic microangiopathies-what intensivists need to know. Crit Care. (2018) 22:158. doi: 10.1186/s13054-018-2073-2 PubMed Abstract | CrossRef Full Text | Google Scholar
101. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG. Thrombocytopenia in patients in the medical intensive care unit: Bleeding prevalence, transfusion requirements, and outcome. Crit Care Med. (2002) 30:1765-71. doi: 10.1097/00003246-200208000-00015 PubMed Abstract | CrossRef Full Text | Google Scholar
102. Koyama K, Katayama S, Muronoi T, Tonai K, Goto Y, Koinuma T, et al. Time course of immature platelet count and its relation to thrombocytopenia and mortality in patients with sepsis. PLoS ONE. (2018) 13:e0192064. doi: 10.1371/journal.pone.0192064 PubMed Abstract | CrossRef Full Text | Google Scholar
103. De Blasi RA, Cardelli P, Costante A, Sandri M, Mercieri M, Arcioni R. Immature platelet fraction in predicting sepsis in critically ill patients. Intensive Care Med. (2013) 39:636-43. doi: 10.1007/s00134-012-2725-7 PubMed Abstract | CrossRef Full Text | Google Scholar
104. Puskarich MA, Cornelius DC, Bandyopadhyay S, McCalmon M, Tramel R, Dale WD, et al. Phosphatidylserine expressing platelet microparticle levels at hospital presentation are decreased in sepsis non-survivors and correlate with thrombocytopenia. Thromb Res. (2018) 168:138-44. doi: 10.1016/j.thromres.2018.06.017 PubMed Abstract | CrossRef Full Text | Google Scholar
105. Elaskalani O, Abdol Razak NB, Metharom P. Neutrophil extracellular traps induce aggregation of washed human platelets independently of extracellular DNA and histones. Cell Commun Signal. (2018) 16:24. doi: 10.1186/s12964-018-0235-0 PubMed Abstract | CrossRef Full Text | Google Scholar
106. Hu H, Armstrong PC, Khalil E, Chen YC, Straub A, Li M, et al. GPVI and GPIbalpha mediate staphylococcal superantigen-like protein 5 (SSL5) induced platelet activation and direct toward glycans as potential inhibitors. PLoS ONE. (2011) 6:e19190. doi: 10.1371/journal.pone.0019190 PubMed Abstract | CrossRef Full Text | Google Scholar
107. Kraemer BF, Campbell RA, Schwertz H, Franks ZG, Vieira de Abreu A, Grundler K, et al. Bacteria differentially induce degradation of Bcl-xL, a survival protein, by human platelets. Blood. (2012) 120:5014-20. doi: 10.1182/blood-2012-04-420661 PubMed Abstract | CrossRef Full Text | Google Scholar
108. Kapur R, Heitink-Polle KM, Porcelijn L, Bentlage AE, Bruin MC, Visser R, et al. C-reactive protein enhances IgG-mediated phagocyte responses and thrombocytopenia. Blood. (2015) 125:1793-802. doi: 10.1182/blood-2014-05-579110 PubMed Abstract | CrossRef Full Text | Google Scholar
109. Johansson D, Rasmussen M, Inghammar M. Thrombocytopenia in bacteraemia and association with bacterial species. Epidemiol Infect. (2018) 146:1312-7. doi: 10.1017/S0950268818001206 PubMed Abstract | CrossRef Full Text | Google Scholar
110. Stark RJ, Aghakasiri N, Rumbaut RE. Platelet-derived Toll-like receptor 4 (Tlr-4) is sufficient to promote microvascular thrombosis in endotoxemia. PLoS ONE. (2012) 7:e41254. doi: 10.1371/journal.pone.0041254 PubMed Abstract | CrossRef Full Text | Google Scholar
111. Semeraro F, Ammollo CT, Morrissey JH, Dale GL, Friese P, Esmon NL, et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: Involvement of platelet TLR2 and TLR4. Blood. (2011) 118:1952-61. doi: 10.1182/blood-2011-03-343061 PubMed Abstract | CrossRef Full Text | Google Scholar
112. Ito T. PAMPs and DAMPs as triggers for DIC. J Intensive Care. (2014) 2:67. doi: 10.1186/s40560-014-0065-0 PubMed Abstract | CrossRef Full Text | Google Scholar
113. Vogel S, Bodenstein R, Chen Q, Feil S, Feil R, Rheinlaender J, et al. Platelet-derived HMGB1 is a critical mediator of thrombosis. J Clin Invest. (2015) 125:4638-54. doi: 10.1172/JCI81660 PubMed Abstract | CrossRef Full Text | Google Scholar
114. Li MF, Li XL, Fan KL, Yu YY, Gong J, Geng SY, et al. Platelet desialylation is a novel mechanism and a therapeutic target in thrombocytopenia during sepsis: An open-label, multicenter, randomized controlled trial. J Hematol Oncol. (2017) 10:104. doi: 10.1186/s13045-017-0476-1 PubMed Abstract | CrossRef Full Text | Google Scholar
115. Kullaya V, de Jonge MI, Langereis JD, van der Gaast-de Jongh CE, Bull C, Adema GJ, et al. Desialylation of platelets by pneumococcal neuraminidase A induces ADP-dependent platelet hyperreactivity. Infect Immun. (2018) 86:e00213-18. doi: 10.1128/IAI.00213-18 PubMed Abstract | CrossRef Full Text | Google Scholar
116. Ghosh TK, Khan N, Malik A. Platelet auto-antibodies in septicaemic patients. Indian J Pathol Microbiol. (1999) 42:31-5. PubMed Abstract | Google Scholar
117. Stephan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, Flahault A. Thrombocytopenia in a surgical ICU. Chest. (1999) 115:1363-70. doi: 10.1378/chest.115.5.1363 PubMed Abstract | CrossRef Full Text | Google Scholar
118. Maharaj S, Chang S. Anti-PF4/heparin antibodies are increased in hospitalized patients with bacterial sepsis. Thromb Res. (2018) 171:111-3. doi: 10.1016/j.thromres.2018.09.060 PubMed Abstract | CrossRef Full Text | Google Scholar
119. Cloutier N, Allaeys I, Marcoux G, Machlus KR, Mailhot B, Zufferey A, et al. Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration. Proc Natl Acad Sci USA. (2018) 115:E1550-9. doi: 10.1073/pnas.1720553115 PubMed Abstract | CrossRef Full Text | Google Scholar
120. Aird WC. The hematologic system as a marker of organ dysfunction in sepsis. Mayo Clin Proc. (2003) 78:869-81. doi: 10.4065/78.7.869 PubMed Abstract | CrossRef Full Text | Google Scholar
121. Jimenez-Alcazar M, Rangaswamy C, Panda R, Bitterling J, Simsek YJ, Long AT, et al. Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science. (2017) 358:1202-6. doi: 10.1126/science.aam8897 PubMed Abstract | CrossRef Full Text | Google Scholar
122. Muronoi T, Koyama K, Nunomiya S, Lefor AK, Wada M, Koinuma T, et al. Immature platelet fraction predicts coagulopathy-related platelet consumption and mortality in patients with sepsis. Thromb Res. (2016) 144:169-75. doi: 10.1016/j.thromres.2016.06.002 PubMed Abstract | CrossRef Full Text | Google Scholar
123. Lupia E, Goffi A, Bosco O, Montrucchio G. Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases. Mediators Inflamm. (2012) 2012:390892. doi: 10.1155/2012/390892 PubMed Abstract | CrossRef Full Text | Google Scholar
124. Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H. Thrombocytopenia in the sepsis syndrome: Role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med. (1997) 103:114-20. doi: 10.1016/S0002-9343(97)00136-8 PubMed Abstract | CrossRef Full Text | Google Scholar
125. Losche W, Boettel J, Kabisch B, Winning J, Claus RA, Bauer M. Do aspirin and other antiplatelet drugs reduce the mortality in critically ill patients? Thrombosis. (2012) 2012:720254. doi: 10.1155/2012/720254 PubMed Abstract | CrossRef Full Text | Google Scholar
126. Winning J, Neumann J, Kohl M, Claus RA, Reinhart K, Bauer M, et al. Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Crit Care Med. (2010) 38:32-7. doi: 10.1097/CCM.0b013e3181b4275c PubMed Abstract | CrossRef Full Text | Google Scholar
127. Thomas MR, Outteridge SN, Ajjan RA, Phoenix F, Sangha GK, Faulkner RE, et al. Platelet P2Y12 inhibitors reduce systemic inflammation and its prothrombotic effects in an experimental human model. Arterioscler Thromb Vasc Biol. (2015) 35:2562-70. doi: 10.1161/ATVBAHA.115.306528 PubMed Abstract | CrossRef Full Text | Google Scholar
128. Sossdorf M, Otto GP, Boettel J, Winning J, Losche W. Benefit of low-dose aspirin and non-steroidal anti-inflammatory drugs in septic patients. Crit Care. (2013) 17:402. doi: 10.1186/cc11886 PubMed Abstract | CrossRef Full Text | Google Scholar
129. Eisen DP, Reid D, McBryde ES. Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis. Crit Care Med. (2012) 40:1761-7. doi: 10.1097/CCM.0b013e318246b9df PubMed Abstract | CrossRef Full Text | Google Scholar
130. Rayes J, Watson SP, Nieswandt B. Functional significance of the platelet immune receptors GPVI and CLEC-2. J Clin Invest. (2019) 129:12-23. doi: 10.1172/JCI122955 PubMed Abstract | CrossRef Full Text | Google Scholar
131. Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol. (2009) 182:7997-8004. doi: 10.4049/jimmunol.0802884 PubMed Abstract | CrossRef Full Text | Google Scholar
132. de Stoppelaar SF, Claushuis TA, Jansen MP, Hou B, Roelofs JJ, van 't Veer C, et al. The role of platelet MyD88 in host response during gram-negative sepsis. J Thromb Haemost. (2015) 13:1709-20. doi: 10.1111/jth.13048 PubMed Abstract | CrossRef Full Text | Google Scholar
133. Ohtaki Y, Shimauchi H, Yokochi T, Takada H, Endo Y. In vivo platelet response to lipopolysaccharide in mice: Proposed method for evaluating new antiplatelet drugs. Thromb Res. (2002) 108:303-9. doi: 10.1016/S0049-3848(03)00092-6 PubMed Abstract | CrossRef Full Text | Google Scholar
134. Corral J, Yelamos J, Hernandez-Espinosa D, Monreal Y, Mota R, Arcas I, et al. Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models. Am J Pathol. (2005) 166:1089-98. doi: 10.1016/S0002-9440(10)62329-2 PubMed Abstract | CrossRef Full Text | Google Scholar
135. Zhao L, Ohtaki Y, Yamaguchi K, Matsushita M, Fujita T, Yokochi T, et al. LPS-induced platelet response and rapid shock in mice: Contribution of O-antigen region of LPS and involvement of the lectin pathway of the complement system. Blood. (2002) 100:3233-9. doi: 10.1182/blood-2002-01-0252 PubMed Abstract | CrossRef Full Text | Google Scholar
136. Shibazaki M, Kawabata Y, Yokochi T, Nishida A, Takada H, Endo Y. Complement-dependent accumulation and degradation of platelets in the lung and liver induced by injection of lipopolysaccharides. Infect Immun. (1999) 67:5186-91. PubMed Abstract | Google Scholar
137. Stortz JA, Raymond SL, Mira JC, Moldawer LL, Mohr AM, Efron PA. Murine models of sepsis and trauma: Can we bridge the gap? ILAR J. (2017) 58:90-105. doi: 10.1093/ilar/ilx007 PubMed Abstract | CrossRef Full Text | Google Scholar
138. Zhang S, Zhang S, Rahman M, Herwald H, Thorlacius H. Streptococcal M1 protein-induced lung injury is independent of platelets in mice. Shock. (2011) 35:86-91. doi: 10.1097/SHK.0b013e3181ea4476 PubMed Abstract | CrossRef Full Text | Google Scholar
139. von Asmuth EJ, Maessen JG, van der Linden CJ, Buurman WA. Tumour necrosis factor alpha (TNF-alpha) and interleukin 6 in a zymosan-induced shock model. Scand J Immunol. (1990) 32:313-9. doi: 10.1111/j.1365-3083.1990.tb02925.x PubMed Abstract | CrossRef Full Text | Google Scholar
140. Xiang B, Zhang G, Guo L, Li XA, Morris AJ, Daugherty A, et al. Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway. Nat Commun. (2013) 4:2657. doi: 10.1038/ncomms3657 PubMed Abstract | CrossRef Full Text | Google Scholar
141. de Stoppelaar SF, van 't Veer C, Claushuis TA, Albersen BJ, Roelofs JJ, van der Poll T. Thrombocytopenia impairs host defense in gram-negative pneumonia-derived sepsis in mice. Blood. (2014) 124:3781-90. doi: 10.1182/blood-2014-05-573915 PubMed Abstract | CrossRef Full Text | Google Scholar
142. Powers ME, Becker RE, Sailer A, Turner JR, Bubeck Wardenburg J. Synergistic action of Staphylococcus aureus alpha-toxin on platelets and myeloid lineage cells contributes to lethal sepsis. Cell Host Microbe. (2015) 17:775-87. doi: 10.1016/j.chom.2015.05.011 PubMed Abstract | CrossRef Full Text | Google Scholar
143. Kahn F, Hurley S, Shannon O. Platelets promote bacterial dissemination in a mouse model of streptococcal sepsis. Microbes Infect. (2013) 15:669-76. doi: 10.1016/j.micinf.2013.05.003 PubMed Abstract | CrossRef Full Text | Google Scholar
144. van den Boogaard FE, Schouten M, de Stoppelaar SF, Roelofs JJ, Brands X, Schultz MJ, et al. Thrombocytopenia impairs host defense during murine Streptococcus pneumoniae pneumonia. Crit Care Med. (2015) 43:e75-83. doi: 10.1097/CCM.0000000000000853 PubMed Abstract | CrossRef Full Text | Google Scholar
145. Cross AS, Opal SM, Sadoff JC, Gemski P. Choice of bacteria in animal models of sepsis. Infect Immun. (1993) 61:2741-7. PubMed Abstract | Google Scholar
146. Feldman C, Shaddock E. Epidemiology of lower respiratory tract infections in adults. Expert Rev Respir Med. (2018). doi: 10.1080/17476348.2019.1555040 PubMed Abstract | CrossRef Full Text | Google Scholar
147. Gow NAR, Yadav B. Microbe profile: Candida albicans: A shape-changing, opportunistic pathogenic fungus of humans. Microbiology. (2017) 163:1145-7. doi: 10.1099/mic.0.000499 PubMed Abstract | CrossRef Full Text | Google Scholar
148. Qin Y, Zhang L, Xu Z, Zhang J, Jiang YY, Cao Y, et al. Innate immune cell response upon Candida albicans infection. Virulence. (2016) 7:512-26. doi: 10.1080/21505594.2016.1138201 PubMed Abstract | CrossRef Full Text | Google Scholar
149. Holder IA, Nathan P. Effect in mice of injection of viable Candida albicans and a cell-free sonic extract on circulating platelets. Infect Immun. (1973) 7:468-72. PubMed Abstract | Google Scholar
150. Li JL, Li G, Jing XZ, Li YF, Ye QY, Jia HH, et al. Assessment of clinical sepsis-associated biomarkers in a septic mouse model. J Int Med Res. (2018) 46:2410-22. doi: 10.1177/0300060518764717 PubMed Abstract | CrossRef Full Text | Google Scholar
151. Vardon Bounes F, Memier V, Marcaud M, Jacquemin A, Hamzeh-Cognasse H, Garcia C, et al. Platelet activation and prothrombotic properties in a mouse model of peritoneal sepsis. Sci Rep. (2018) 8:13536. doi: 10.1038/s41598-018-31910-8 PubMed Abstract | CrossRef Full Text | Google Scholar
152. Dejager L, Pinheiro I, Dejonckheere E, Libert C. Cecal ligation and puncture: The gold standard model for polymicrobial sepsis? Trends Microbiol. (2011) 19:198-208. doi: 10.1016/j.tim.2011.01.001 PubMed Abstract | CrossRef Full Text | Google Scholar
153. Buras JA, Holzmann B, Sitkovsky M. Animal models of sepsis: Setting the stage. Nat Rev Drug Discov. (2005) 4:854-65. doi: 10.1038/nrd1854 PubMed Abstract | CrossRef Full Text | Google Scholar
154. Singer G, Houghton J, Rivera CA, Anthoni C, Granger DN. Role of LPS in the hepatic microvascular dysfunction elicited by cecal ligation and puncture in mice. J Hepatol. (2007) 47:799-806. doi: 10.1016/j.jhep.2007.07.021 PubMed Abstract | CrossRef Full Text | Google Scholar
155. Remick DG, Newcomb DE, Bolgos GL, Call DR. Comparison of the mortality and inflammatory response of two models of sepsis: Lipopolysaccharide vs. cecal ligation and puncture. Shock. (2000) 13:110-6. doi: 10.1097/00024382-200013020-00004 PubMed Abstract | CrossRef Full Text | Google Scholar
156. Gentile LF, Nacionales DC, Lopez MC, Vanzant E, Cuenca A, Szpila BE, et al. Host responses to sepsis vary in different low-lethality murine models. PLoS ONE. (2014) 9:e94404. doi: 10.1371/journal.pone.0094404 PubMed Abstract | CrossRef Full Text | Google Scholar
157. Claushuis TAM, de Vos AF, Nieswandt B, Boon L, Roelofs J, de Boer OJ, et al. Platelet glycoprotein VI aids in local immunity during pneumonia-derived sepsis caused by gram-negative bacteria. Blood. (2018) 131:864-76. doi: 10.1182/blood-2017-06-788067 PubMed Abstract | CrossRef Full Text | Google Scholar
158. Zarbock A, Singbartl K, Ley K. Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest. (2006) 116:3211-9. doi: 10.1172/JCI29499 PubMed Abstract | CrossRef Full Text | Google Scholar
159. Wuescher LM, Takashima A, Worth RG. A novel conditional platelet depletion mouse model reveals the importance of platelets in protection against Staphylococcus aureus bacteremia. J Thromb Haemost. (2015) 13:303-13. doi: 10.1111/jth.12795 PubMed Abstract | CrossRef Full Text | Google Scholar
160. Camerer E, Cornelissen I, Kataoka H, Duong DN, Zheng YW, Coughlin SR. Roles of protease-activated receptors in a mouse model of endotoxemia. Blood. (2006) 107:3912-21. doi: 10.1182/blood-2005-08-3130 PubMed Abstract | CrossRef Full Text | Google Scholar
161. de Stoppelaar SF, Van't Veer C, van den Boogaard FE, Nieuwland R, Hoogendijk AJ, de Boer OJ, et al. Protease activated receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice. Thromb Haemost. (2013) 110:582-92. doi: 10.1160/TH13-01-0052 PubMed Abstract | CrossRef Full Text | Google Scholar
162. de Stoppelaar SF, Van't Veer C, Roelofs JJ, Claushuis TA, de Boer OJ, Tanck MW, et al. Platelet and endothelial cell P-selectin are required for host defense against Klebsiella pneumoniae-induced pneumosepsis. J Thromb Haemost. (2015) 13:1128-38. doi: 10.1111/jth.12893 PubMed Abstract | CrossRef Full Text | Google Scholar
163. Asaduzzaman M, Rahman M, Jeppsson B, Thorlacius H. P-selectin glycoprotein-ligand-1 regulates pulmonary recruitment of neutrophils in a platelet-independent manner in abdominal sepsis. Br J Pharmacol. (2009) 156:307-15. doi: 10.1111/j.1476-5381.2008.00021.x PubMed Abstract | CrossRef Full Text | Google Scholar
164. Rahman M, Zhang S, Chew M, Syk I, Jeppsson B, Thorlacius H. Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis. J Thromb Haemost. (2013) 11:1385-98. doi: 10.1111/jth.12273 PubMed Abstract | CrossRef Full Text | Google Scholar
165. Asaduzzaman M, Lavasani S, Rahman M, Zhang S, Braun OO, Jeppsson B, et al. Platelets support pulmonary recruitment of neutrophils in abdominal sepsis. Crit Care Med. (2009) 37:1389-96. doi: 10.1097/CCM.0b013e31819ceb71 PubMed Abstract | CrossRef Full Text | Google Scholar
166. Yin H, Stojanovic-Terpo A, Xu W, Corken A, Zakharov A, Qian F, et al. Role for platelet glycoprotein Ib-IX and effects of its inhibition in endotoxemia-induced thrombosis, thrombocytopenia, and mortality. Arterioscler Thromb Vasc Biol. (2013) 33:2529-37. doi: 10.1161/ATVBAHA.113.302339 PubMed Abstract | CrossRef Full Text | Google Scholar
167. Corken A, Russell S, Dent J, Post SR, Ware J. Platelet glycoprotein Ib-IX as a regulator of systemic inflammation. Arterioscler Thromb Vasc Biol. (2014) 34:996-1001. doi: 10.1161/ATVBAHA.113.303113 PubMed Abstract | CrossRef Full Text | Google Scholar
168. Rayes J, Lax S, Wichaiyo S, Watson SK, Di Y, Lombard S, et al. The podoplanin-CLEC-2 axis inhibits inflammation in sepsis. Nat Commun. (2017) 8:2239. doi: 10.1038/s41467-017-02402-6 PubMed Abstract | CrossRef Full Text | Google Scholar
169. Hitchcock JR, Cook CN, Bobat S, Ross EA, Flores-Langarica A, Lowe KL, eta l. Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets. J Clin Invest. (2015) 125:4429-46. doi: 10.1172/JCI79070 PubMed Abstract | CrossRef Full Text | Google Scholar
170. Claushuis TAM, de Stoppelaar SF, de Vos AF, Grootemaat AE, van der Wel NN, Roelofs J, et al. Nbeal2 deficiency increases organ damage but does not affect host defense during gram-negative pneumonia-derived sepsis. Arterioscler Thromb Vasc Biol. (2018) 38:1772-84. doi: 10.1161/ATVBAHA.118.311332 CrossRef Full Text | Google Scholar
171. Hwaiz R, Rahman M, Zhang E, Thorlacius H. Platelet secretion of CXCL4 is Rac1-dependent and regulates neutrophil infiltration and tissue damage in septic lung damage. Br J Pharmacol. (2015) 172:5347-59. doi: 10.1111/bph.13325 PubMed Abstract | CrossRef Full Text | Google Scholar
172. Hwaiz R, Rahman M, Syk I, Zhang E, Thorlacius H. Rac1-dependent secretion of platelet-derived CCL5 regulates neutrophil recruitment via activation of alveolar macrophages in septic lung injury. J Leukoc Biol. (2015) 97:975-84. doi: 10.1189/jlb.4A1214-603R PubMed Abstract | CrossRef Full Text | Google Scholar
173. Grommes J, Alard JE, Drechsler M, Wantha S, Morgelin M, Kuebler WM, et al. Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury. Am J Respir Crit Care Med. (2012) 185:628-36. doi: 10.1164/rccm.201108-1533OC PubMed Abstract | CrossRef Full Text | Google Scholar
174. Kowalska MA, Mahmud SA, Lambert MP, Poncz M, Slungaard A. Endogenous platelet factor 4 stimulates activated protein C generation in vivo and improves survival after thrombin or lipopolysaccharide challenge. Blood. (2007) 110:1903-5. doi: 10.1182/blood-2007-03-081901 CrossRef Full Text | Google Scholar
175. Duerschmied D, Suidan GL, Demers M, Herr N, Carbo C, Brill A, et al. Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. Blood. (2013) 121:1008-15. doi: 10.1182/blood-2012-06-437392 PubMed Abstract | CrossRef Full Text | Google Scholar
176. Zhou H, Deng M, Liu Y, Yang C, Hoffman R, Zhou J, et al. Platelet HMGB1 is required for efficient bacterial clearance in intra-abdominal bacterial sepsis in mice. Blood Adv. (2018) 2:638-48. doi: 10.1182/bloodadvances.2017011817 PubMed Abstract | CrossRef Full Text | Google Scholar
177. Freishtat RJ, Natale J, Benton AS, Cohen J, Sharron M, Wiles AA, et al. Sepsis alters the megakaryocyte-platelet transcriptional axis resulting in granzyme B-mediated lymphotoxicity. Am J Respir Crit Care Med. (2009) 179:467-73. doi: 10.1164/rccm.200807-1085OC PubMed Abstract | CrossRef Full Text | Google Scholar
178. Sharron M, Hoptay CE, Wiles AA, Garvin LM, Geha M, Benton AS, et al. Platelets induce apoptosis during sepsis in a contact-dependent manner that is inhibited by GPIIb/IIIa blockade. PLoS ONE. (2012) 7:e41549. doi: 10.1371/journal.pone.0041549 PubMed Abstract | CrossRef Full Text | Google Scholar
179. Mederle K, Meurer M, Castrop H, Hocherl K. Inhibition of COX-1 attenuates the formation of thromboxane A2 and ameliorates the acute decrease in glomerular filtration rate in endotoxemic mice. Am J Physiol Renal Physiol. (2015) 309:F332-40. doi: 10.1152/ajprenal.00567.2014 PubMed Abstract | CrossRef Full Text | Google Scholar
180. Liverani E, Rico MC, Yaratha L, Tsygankov AY, Kilpatrick LE, Kunapuli SP. LPS-induced systemic inflammation is more severe in P2Y12 null mice. J Leukoc Biol. (2014) 95:313-23. doi: 10.1189/jlb.1012518 PubMed Abstract | CrossRef Full Text | Google Scholar
181. Liverani E, Rico MC, Tsygankov AY, Kilpatrick LE, Kunapuli SP. P2Y12 Receptor modulates sepsis-induced inflammation. Arterioscler Thromb Vasc Biol. (2016) 36:961-71. doi: 10.1161/ATVBAHA.116.307401 PubMed Abstract | CrossRef Full Text | Google Scholar
182. Rahman M, Gustafsson D, Wang Y, Thorlacius H, Braun OO. Ticagrelor reduces neutrophil recruitment and lung damage in abdominal sepsis. Platelets. (2014) 25:257-63. doi: 10.3109/09537104.2013.809520 PubMed Abstract | CrossRef Full Text | Google Scholar
183. Totani L, Dell'Elba G, Martelli N, Di Santo A, Piccoli A, Amore C, et al. Prasugrel inhibits platelet-leukocyte interaction and reduces inflammatory markers in a model of endotoxic shock in the mouse. Thromb Haemost. (2012) 107:1130-40. doi: 10.1160/TH11-12-0867 PubMed Abstract | CrossRef Full Text | Google Scholar
184. Li X, Li Y, Shen K, Li H, Bai J. The protective effect of ticagrelor on renal function in a mouse model of sepsis-induced acute kidney injury. Platelets. (2018) 30:199-205. doi: 10.1080/09537104.2017.1392499 PubMed Abstract | CrossRef Full Text | Google Scholar
185. Claushuis TAM, de Vos AF, Roelofs J, de Boer OJ, van 't Veer C, van der Poll T. Platelet-dense granules worsen pre-infection thrombocytopenia during gram-negative pneumonia-derived sepsis. J Innate Immun. (2018) 11:168-80. doi: 10.1159/000494147 PubMed Abstract | CrossRef Full Text | Google Scholar
186. Seidel M, Winning J, Claus RA, Bauer M, Losche W. Beneficial effect of clopidogrel in a mouse model of polymicrobial sepsis. J Thromb Haemost. (2009) 7:1030-2. doi: 10.1111/j.1538-7836.2009.03352.x PubMed Abstract | CrossRef Full Text | Google Scholar
187. Cornelius DC, Baik CH, Travis OK, White DL, Young CM, Austin Pierce W, et al. NLRP3 inflammasome activation in platelets in response to sepsis. Physiol Rep. (2019) 7:e14073. doi: 10.14814/phy2.14073 PubMed Abstract | CrossRef Full Text | Google Scholar
188. Lopes Pires ME, Antunes Naime AC, Oliveira JGF, Anhe GF, Garraud O, Cognasse F, et al. Signalling pathways involved in p47(phox) -dependent reactive oxygen species in platelets of endotoxemic rats. Basic Clin Pharmacol Toxicol. (2019) 124:394-403. doi: 10.1111/bcpt.13148 CrossRef Full Text | Google Scholar
189. Liverani E, Mondrinos MJ, Sun S, Kunapuli SP, Kilpatrick LE. Role of Protein Kinase C-delta in regulating platelet activation and platelet-leukocyte interaction during sepsis. PLoS ONE. (2018) 13:e0195379. doi: 10.1371/journal.pone.0195379 PubMed Abstract | CrossRef Full Text | Google Scholar
190. Steven S, Dib M, Roohani S, Kashani F, Munzel T, Daiber A. Time response of oxidative/nitrosative stress and inflammation in LPS-induced endotoxaemia-A comparative study of mice and rats. Int J Mol Sci. (2017) 18:E2176. doi: 10.3390/ijms18102176 PubMed Abstract | CrossRef Full Text | Google Scholar
191. Sellers RS, Clifford CB, Treuting PM, Brayton C. Immunological variation between inbred laboratory mouse strains: Points to consider in phenotyping genetically immunomodified mice. Vet Pathol. (2012) 49:32-43. doi: 10.1177/0300985811429314 PubMed Abstract | CrossRef Full Text | Google Scholar
192. Carreras E, Velasco de Andres M, Orta-Mascaro M, Simoes IT, Catala C, Zaragoza O, et al. Discordant susceptibility of inbred C57BL/6 versus outbred CD1 mice to experimental fungal sepsis. Cell Microbiol. (2018) 21:e12995. doi: 10.1111/cmi.12995 PubMed Abstract | CrossRef Full Text | Google Scholar
193. Wiedmeyer CE, Ruben D, Franklin C. Complete blood count, clinical chemistry, and serology profile by using a single tube of whole blood from mice. J Am Assoc Lab Anim Sci. (2007) 46:59-64. PubMed Abstract | Google Scholar
194. McKenzie SE, Taylor SM, Malladi P, Yuhan H, Cassel DL, Chien P, et al. The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: A transgenic mouse model. J Immunol. (1999) 162:4311-8. PubMed Abstract | Google Scholar
195. French SL, Paramitha AC, Moon MJ, Dickins RA, Hamilton JR. Humanizing the protease-activated receptor (PAR) expression profile in mouse platelets by knocking PAR1 into the Par3 locus reveals PAR1 expression is not tolerated in mouse platelets. PLoS ONE. (2016) 11:e0165565. doi: 10.1371/journal.pone.0165565 CrossRef Full Text | Google Scholar
196. Arachiche A, de la Fuente M, Nieman MT. Platelet specific promoters are insufficient to express protease activated receptor 1 (PAR1) transgene in mouse platelets. PLoS ONE. (2014) 9:e97724. doi: 10.1371/journal.pone.0097724 PubMed Abstract | CrossRef Full Text | Google Scholar
197. Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D, Inflammation and the Host Response to Injury Investigators. Acute inflammatory response to endotoxin in mice and humans. Clin Diagn Lab Immunol. (2005) 12:60-7. doi: 10.1128/CDLI.12.1.60-67.2005 PubMed Abstract | CrossRef Full Text | Google Scholar
198. Warren HS, Fitting C, Hoff E, Adib-Conquy M, Beasley-Topliffe L, Tesini B, et al. Resilience to bacterial infection: Difference between species could be due to proteins in serum. J Infect Dis. (2010) 201:223-32. doi: 10.1086/649557 PubMed Abstract | CrossRef Full Text | Google Scholar